Chip stocks fall with Nvidia after data center rev disappointment
VitaSpring Biomedical Co. Ltd. (VSBC) announced Monday that its board of directors has approved the engagement of JP Centurion & Partners PLT as the company’s independent registered public accounting firm, effective August 19. The announcement was made in a statement based on a filing with the Securities and Exchange Commission.
According to the filing, JP Centurion is registered with the Public Company Accounting Oversight Board and will be responsible for auditing VitaSpring Biomedical’s consolidated financial statements and conducting required review procedures for the company’s periodic reports.
The company stated that during the two most recent fiscal years and the interim period through August 19, neither VitaSpring Biomedical nor anyone acting on its behalf had consulted with JP Centurion regarding the application of accounting principles to any specific transaction or the type of audit opinion that might be rendered on its financial statements. The filing also notes that JP Centurion did not provide any written report or oral advice that was a factor in the company’s decision-making on accounting, auditing, or financial reporting matters.
VitaSpring Biomedical previously disclosed the resignation of its former independent registered public accounting firm in a report filed with the SEC on August 7. The current announcement is limited to the engagement of JP Centurion as the new auditor.
VitaSpring Biomedical Co. Ltd. is incorporated in Nevada and its common stock trades under the symbol VSBC. The company is not currently listed on any securities exchange.
This information is based on a press release statement filed with the Securities and Exchange Commission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.